-
My Account
My Account
BSE Live
Apr 22, 16:00Prev. Close
802.20
Open Price
818.25
Bid Price (Qty.)
817.35 (10)
Offer Price (Qty.)
817.35 (10)
NSE Live
Apr 22, 15:59Prev. Close
801.90
Open Price
813.90
Bid Price (Qty.)
817.65 (1)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of Jubilant Pharmova (in Rs. Cr.) | Dec '20 | Sep '20 | Jun '20 | Mar '20 | Dec '19 | |
| Net Sales/Income from operations | 825.92 | 753.78 | 743.57 | 778.44 | 788.87 | |
| Other Operating Income | 3.02 | 6.97 | 10.38 | 12.92 | 12.31 | |
| Total Income From Operations | 828.94 | 760.75 | 753.95 | 791.36 | 801.18 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 402.42 | 383.35 | 365.83 | 427.28 | 440.13 | |
| Purchase of Traded Goods | 20.73 | 18.94 | 19.15 | 31.14 | 19.36 | |
| Increase/Decrease in Stocks | 32.41 | 1.93 | 11.56 | -47.77 | -33.80 | |
| Power & Fuel | 86.22 | 84.52 | 80.16 | 89.13 | 97.44 | |
| Employees Cost | 64.85 | 61.43 | 59.61 | 67.43 | 69.76 | |
| depreciat | 29.85 | 29.59 | 29.53 | 29.80 | 28.49 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 100.91 | 91.44 | 86.29 | 130.51 | 113.87 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 91.55 | 89.55 | 101.82 | 63.84 | 65.93 | |
| Other Income | 12.21 | 12.89 | 8.98 | 82.69 | 5.52 | |
| P/L Before Int., Excpt. Items & Tax | 103.76 | 102.44 | 110.80 | 146.53 | 71.45 | |
| Interest | 22.77 | 27.21 | 39.72 | 36.17 | 34.79 | |
| P/L Before Exceptional Items & Tax | 80.99 | 75.23 | 71.08 | 110.36 | 36.66 | |
| Exceptional Items | -- | -- | -- | -- | -1.70 | |
| P/L Before Tax | 80.99 | 75.23 | 71.08 | 110.36 | 34.96 | |
| Tax | 16.34 | 12.60 | 19.04 | -0.82 | 0.33 | |
| P/L After Tax from Ordinary Activities | 64.65 | 62.63 | 52.04 | 111.18 | 34.63 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 64.65 | 62.63 | 52.04 | 111.18 | 34.63 | |
| Equity Share Capital | 15.93 | 15.93 | 15.93 | 15.93 | 15.93 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 4.06 | 3.93 | 3.27 | 6.98 | 2.17 | |
| Diluted EPS | 4.06 | 3.93 | 3.27 | 6.98 | 2.17 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 4.06 | 3.93 | 3.27 | 6.98 | 2.17 | |
| Diluted EPS. | 4.06 | 3.93 | 3.27 | 6.98 | 2.17 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
09.02.2021
Jubilant Life Consolidated December 2020 Net Sales at Rs 1,771.34 crore, down 23.49% Y-o-Y
06.11.2020
Jubilant Life Standalone September 2020 Net Sales at Rs 760.75 crore, up 0.42% Y-o-Y
05.11.2020
Jubilant Life Sciences Q2 net profit declines 10% to Rs 224 crore
05.11.2020
Jubilant Life Consolidated September 2020 Net Sales at Rs 2,374.89 crore, up 4.81% Y-o-Y
18.01.2021
Jubilant Life Sciences Q3 PAT seen up 14.9% YoY to Rs. 238 cr: Prabhudas Lilladher
12.07.2019
Jubilant Life Sciences Q1 PAT may dip 10.4% YoY to Rs. 181.4 cr: Prabhudas Lilladher
12.04.2019
Jubilant Life Sciences Q4 PAT seen up 36.3% YoY to Rs. 211.2 cr: Prabhudas Lilladher
11.01.2019
Jubilant Life Science Q3 PAT seen up 13.8% YoY to Rs. 241.8 cr: ICICI Direct
